Stocks in Play

BioVaxys Technology Corp

10:01 AM EST - BioVaxys Technology Corp : Announces it has completed the acquisition of the entire portfolio of discovery, preclinical and clinical development stage assets of former Canadian biotechnology company, IMV Inc., Immunovaccine Technologies Inc., and IMV USA. BioVaxys Technology Corp shares C.BIOV are trading unchanged at $0.09.

Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BIOV%3ACNX&qmodStoryID=7399993940267022